Cambria Cannabis ETF
TOKE

$6.18

0.65%

Market Cap: $16.7M

0

Funds holding %

of 6,710 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

104% more call options, than puts

Call options by funds: $57K | Put options by funds: $28K

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

7% more capital invested

Capital invested by funds: $1.34M [Q1] → $1.44M (+$97.7K) [Q2]

0.32% less ownership

Funds ownership: 12.65% [Q1] → 12.33% (-0.32%) [Q2]

6% less funds holding

Funds holding: 17 [Q1] → 16 (-1) [Q2]

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for TOKE.

See Analyst Rankings

Financial journalist opinion

The 2024 Millionaire's Club: 7 Cannabis Stocks to Buy Now

One of the hottest topics of the year has been cannabis stocks to buy, especially with elections nearing. We can see that with more than 88% of Americans wanting to see legalization.

The 2024 Millionaire's Club: 7 Cannabis Stocks to Buy Now

ETF Prime: Rosenbluth on Spot Ether, Marijuana ETFs, and More

On this week's episode of ETF Prime, host Nate Geraci is joined by VettaFi Head of Research Todd Rosenbluth to discuss hedge funds embracing ETFs, spot ether ETFs, and a potential shortage of ETF tickers, among other topics. Afterward, Bancreek CEO and CIO Andrew Skatoff spoke with Geraci about his investment philosophy.

ETF Prime: Rosenbluth on Spot Ether, Marijuana ETFs, and More

Mario Naric On Canada's Shakeout Phase

The Canadian cannabis industry is in a shakeout phase, with poorly run businesses struggling and the industry maturing.

Mario Naric On Canada's Shakeout Phase

Zacks Investment Research

Philip Morris Beats Estimates in Q1 Earnings: ETFs in Focus

Philip Morris beat expectations for both revenues and earnings, driven by robust pricing and increased product volumes.

Philip Morris Beats Estimates in Q1 Earnings: ETFs in Focus

Road to Full Cannabis Legalization in the U.S.

Morgan Paxhia discusses the latest trends in the cannabis space. He talks about the road to full cannabis legalization in the U.S. He then goes over the best positioned cannabis stocks.

Road to Full Cannabis Legalization in the U.S.

ETF Themes That Dominated in Q1 2023

As the first quarter comes to a close, clearly, there have been some thematic winners in terms of flows and investment performance. Artificial Intelligence AI-themed ETFs remain among the top recipients of investor flows this year.

ETF Themes That Dominated in Q1 2023

Understanding Cannabis ETFs' Wacky Divergence

One of the top-performing thematic segments this year is cannabis. A major catalyst has been the proposed descheduling of it from a Schedule I to a Schedule III drug under the Controlled Substances Act (CSA).

Understanding Cannabis ETFs' Wacky Divergence

Investing In Cannabis? Stay Patient, Be Ready

Cannabis investors are tired of waiting and losing money, but there are still reasons to be optimistic in the long term.

Investing In Cannabis? Stay Patient, Be Ready

See News Rankings